These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16983770)

  • 1. [Novel actions of calcium channel blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Hayashi K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():311-7. PubMed ID: 16983770
    [No Abstract]   [Full Text] [Related]  

  • 2. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
    Nagasu H; Satoh M; Fujimoto S; Tomita N; Sasaki T; Kashihara N
    Hypertens Res; 2012 Mar; 35(3):348-55. PubMed ID: 22072106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in older adults: progress and limitations.
    Rich MW
    Am J Med; 2012 Oct; 125(10):949-50. PubMed ID: 22902034
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients.
    Suzuki H; Inoue T; Kobayashi K; Shoda J; Nakamoto H
    Adv Perit Dial; 2006; 22():18-23. PubMed ID: 16983932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blocker inhibition of AGE and RAGE axis limits renal injury in nondiabetic patients with stage I or II chronic kidney disease.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Koide H; Ueda Y; Takeuchi M; Yamagishi S
    Clin Cardiol; 2011 Jun; 34(6):372-7. PubMed ID: 21432860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
    Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T
    Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering the sympathomodulatory properties of new calcium channel blockers: an exciting but still snaky journey.
    Grassi G
    J Hypertens; 2014 Sep; 32(9):1780-1. PubMed ID: 25098784
    [No Abstract]   [Full Text] [Related]  

  • 9. Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Inoue T; Node K
    Am J Med Sci; 2007 Jun; 333(6):321-6. PubMed ID: 17570983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo Medical University].
    Miyauchi K; Daida H
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):3002-11. PubMed ID: 23214115
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function--a crossover trial (AGENT).
    Fukao K; Shimada K; Hiki M; Kiyanagi T; Hirose K; Kume A; Ohsaka H; Matsumori R; Kurata T; Miyazaki T; Daida H
    Cardiovasc Diabetol; 2011 Sep; 10():79. PubMed ID: 21906391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients.
    Koike Y; Kawabe T; Nishihara K; Iwane N; Hano T
    Hypertens Res; 2016 Dec; 39(12):863-867. PubMed ID: 27439493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
    Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Nawada R; Obayashi K; Togi K; Miho N
    Hypertension; 1999 Jun; 33(6):1447-52. PubMed ID: 10373231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
    Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A
    Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
    Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
    J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
    Fujisawa M; Yorikane R; Chiba S; Koike H
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J).
    Miyauchi K; Kojima T; Yokoyama T; Kurata T; Yokoyama K; Kawamura M; Suwa S; Okazaki S; Inoue K; Fujiwara Y; Sumiyoshi M; Tanimoto K; Nakazato Y; Yamagami S; Daida H
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):409-13. PubMed ID: 19763803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-/T-type Ca channel blockers for kidney protection: ready for sophisticated use of Ca channel blockers.
    Hayashi K
    Hypertens Res; 2011 Aug; 34(8):910-2. PubMed ID: 21753772
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction.
    Zaliūnas R; Brazdzionyte J; Zabiela V; Jurkevicius R
    Int J Cardiol; 2005 Jun; 101(3):347-53. PubMed ID: 15907400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.